Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133647) titled 'Innovative Practical Research on Cutaneous Inflammatory Reactions in Tumor Patients Undergoing Immunotherapy Driven by the JBI Model' on Sept. 30.
Study Type: Interventional study
Study Design:
Non randomized control
Primary Sponsor: Shanghai General Hospital
Condition:
cutaneous inflammatory reactions associated with immunotherapy for malignant tumors
Intervention:
Intervention group:Evidence-based nursing intervention group
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-30
Target Sample Size: Intervention group:38;Control group:38;
Countries of Recruitment:
China...